Dogs can develop a form of dementia known as Canine Cognitive Dysfunction (CCD), a condition that shares several characteristics with Alzheimer’s disease in humans. This neurological disorder results from physical changes in the brain and its chemical environment, according to recent findings.

Studies have revealed that, like humans with Alzheimer’s, aging dogs accumulate deposits of beta-amyloid protein in their brains. In both species, this protein aggregates into plaques that disrupt neural communication. These plaques contribute to the loss of neurons responsible for cognitive functions such as memory and thinking. However, unlike Alzheimer’s in humans, advanced-stage features such as the formation of neurofibrillary tangles have not been observed in dogs with CCD. As a result, canine dementia is considered to parallel only the early to intermediate phases of human Alzheimer’s disease.

The underlying cause of CCD is believed to involve damage inflicted on the brain by free radicals—unstable molecules that can harm cells. Young dogs typically produce antioxidants that counteract the effects of free radicals, protecting brain tissue. However, this antioxidant production declines with age, increasing the brain’s vulnerability to oxidative damage.

While the condition primarily affects older dogs, it can significantly impact their behavior and quality of life. Symptoms of CCD may include confusion, disorientation, altered interaction with humans or other animals, disrupted sleep patterns, and changes in activity levels.

Experts continue to explore the mechanisms behind CCD to better understand its progression and develop potential treatments. The similarities between canine and human cognitive decline underscore the importance of further research, which may provide mutual insights into managing dementia across species.